Management of GMP compliance signals
Date
Disclaimer
This presentation paper is provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The paper is not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation paper should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: Darika Sowana
- Presented at: Online
- Presentation date: 14 May 2021
- Presentation summary: An overview of GMP compliance signals, how we manage these signals for manufacturers of medicines and biologicals and the kind of information that may be required in the assessment of these signals
Webinar presentation: Management of GMP Compliance signals (pdf,899kb)
Topics
Related content
-
GMP Clearance backlog reduction strategy
Learn about the temporary risk-based strategies being introduced on 1 July 2025 to expedite the reduction of the Good Manufacturing Practice (GMP) Clearance Compliance Verification (CV) backlog.